Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
11/2003
11/12/2003EP1360314A2 Chemically defined medium for cultured mammalian cells
11/12/2003EP1360304A2 Enzymes
11/12/2003EP1360299A2 The genome of a bifidobacterium
11/12/2003EP1360297A2 Ragweed allergens
11/12/2003EP1360295A2 Molecules for desease detection and treatment
11/12/2003EP1360293A2 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
11/12/2003EP1360291A2 Human polynucleotides and polypeptides encoded thereby
11/12/2003EP1360287A1 Methods of modifying eukaryotic cells
11/12/2003EP1360282A2 Degradation and detection of tse infectivity
11/12/2003EP1360281A2 Regulation of human wee1-like serine/threonine protein kinase
11/12/2003EP1360279A2 Novel form of the phgpx protein as a diagnostic marker for male infertility
11/12/2003EP1360278A2 Lipase variants
11/12/2003EP1360199A2 Treatment involving dkk-1 or antagonists thereof
11/12/2003EP1360197A2 Histidine phosphatase interacting protein with 240kd
11/12/2003EP1360193A1 Method for purifying the helicobacter adhesin-like protein a (alpa)
11/12/2003EP1359883A2 (psi)(epsilon)rack peptide composition and method for protection against tissue damage due to ischemia
11/12/2003EP0994904B1 Amino acid sequences for therapeutical and prophylactic applications to diseases due to clostridium difficile toxins
11/12/2003EP0897390B1 Human tumor necrosis factor delta and epsilon
11/12/2003EP0773952B1 Interaction trap systems for detecting protein interactions
11/12/2003EP0759759B1 P75 tnf receptor promoters
11/12/2003EP0742829B1 Expression of heterologous proteins in attenuated bacteria using the htra-promoters
11/12/2003EP0741515B1 Transgenic production of antibodies in milk
11/12/2003EP0513336B1 New variants derived from interferons of type i, production process thereof and their applications
11/12/2003CN1455813A Human myeloma cell line
11/12/2003CN1455001A Exendin-4 polypeptide preparation method
11/12/2003CN1454989A Yeast genetically engineered strain expressing hrp gene and constructing method thereof
11/12/2003CN1454902A Mitochondria creatinekinase antibody
11/12/2003CN1127571C Permentative production of valuable compounds on industrial scale using chemically defined media
11/12/2003CN1127569C Method for mass production of antimicrobial peptide
11/12/2003CN1127568C Fibroblast growth factor homologs
11/12/2003CN1127518C Preparation of recombinant factor  in protein free medium
11/12/2003CN1127517C Trophic fuctors for central nervous system
11/12/2003CN1127351C Method for inducing antigen-specific T cell tolerance
11/11/2003USRE38313 4 immunoglobulin type extracellular domains having arginine residues substituted by glutamic acid; immunosuppressants; preventing specific binding to major histocompatibility complex
11/11/2003US6646116 Variant tax gene of bovine leukemia virus
11/11/2003US6646109 Antibody that binds specifically; blocked by nicotine
11/11/2003US6645937 Methods using persephin and related growth factors
11/11/2003US6645933 Polypeptide that binds extracellular domain of human Flt4 receptor tyrosine kinase; genetic engineering; endothelial cell growth factors and genes
11/11/2003US6645774 Administering for treatment of obesity, bulimia or anorexia
11/11/2003US6645761 Use to enhance the expression of the encoded polypeptide in mammalian cells
11/11/2003US6645760 Negative strand RNA viral vector having autonomous replication capability
11/11/2003US6645753 Polynucleotides; antisense agents; MAP-kinases; nucleotide sequences; use of polypeptides to identify agents modulating signal transduction leading to cell proliferation, differen-tiation, survival and treatment of such conditions (cancer)
11/11/2003US6645751 Nucleic acid isolated from Tetrahymena which codes for a triterpenoid cyclase, its production, and use
11/11/2003US6645734 Diagnosis of Alzheimer's disease
11/11/2003US6645726 Canine growth hormone secretagogue receptor
11/11/2003US6645723 Method for determining cytokine receptor activation by the use of an antibody
11/11/2003US6645509 Treating the thinning of the epidermis with said polypeptide
11/11/2003US6645501 Anti-pathogen system and methods of use thereof
11/11/2003US6645500 Method for down-regulating osteoprotegerin ligand activity
11/11/2003US6645494 An antibody, or a binding fragment thereof, specific for human CD40L antigen conjugated to a Type I ribosome inactivating protein
11/11/2003US6645492 For diagnosis and therapy of susceptibility to atopic allergy, asthma
11/11/2003US6645484 Endothelial cell transmembrane tyrosine kinase ligand
11/11/2003CA2210294C Immunogenic compositions containing recombinant attenuated poxviruses expressing htlv antigens
11/11/2003CA2116774C Expression in e. coli antibody fragments having at least a cysteine present as a free thiol. use for the production of bifunctional f(ab') 2 antibodies
11/11/2003CA2056279C Cell-free receptor binding assays, the production and use thereof
11/06/2003WO2003091437A1 Chimeric camp factors for vaccination against streptococcus infection
11/06/2003WO2003091435A1 Novel proteins and dnas encoding the same
11/06/2003WO2003091431A1 Methylotroph producing mammalian type sugar chain
11/06/2003WO2003091424A1 Method of screening agonistic antibody
11/06/2003WO2003091414A2 Adipocyte complement related protein zacrp8
11/06/2003WO2003091413A2 Expression of polypeptides in chloroplasts, and compositions and methods for expressing same
11/06/2003WO2003091404A2 Formation and use of site specific nucleic acid coupled binding polypeptides
11/06/2003WO2003091273A2 Protein interaction system for multisubunit complexes
11/06/2003WO2003091266A2 Protein stabilisation using chaperone proteins
11/06/2003WO2003090514A2 Adipocyte complement related protein zacrp14
11/06/2003WO2003090513A2 Bi-specific antigen-binding compositions and related methods
11/06/2003WO2003059945A3 Soluble recombinant protein production
11/06/2003WO2003048327A3 Anti-cd45rb antibodies for use in treating autoimmune disease and transplant rejection
11/06/2003WO2003046570A3 Glycoprotein and apolipoprotein biopolymer markers predictive of alzheimers disease
11/06/2003WO2003031939A3 Protein modification and maintenance molecules
11/06/2003WO2003027263A3 Proteins associated with cell growth, differentiation, and death
11/06/2003WO2003023021A3 Methods for producing an active constituent of a pharmaceutical or a diagnostic agent in an mdck cell suspension culture
11/06/2003WO2003012069A3 Compositions and methods for generating chimeric heteromultimers
11/06/2003WO2003011878A3 Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
11/06/2003WO2003006506A3 Protease inhibitor conjugates and antibodies useful in immunoassay
11/06/2003WO2003002604A3 G protein coupled receptors and dna sequences thereof
11/06/2003WO2002083711A3 Molecular mimetics of meningococcal b epitopes which elicit functionally active antibodies
11/06/2003WO2002072600A3 Monoclonal antibodies to the clfa protein and method of use in treating or preventing infections
11/06/2003WO2002070667A3 High level insect expression of rage proteins
11/06/2003WO2002070657A8 93870, a human g-protein coupled receptor and uses therefor
11/06/2003WO2002066649A8 ANTI-INTERFERON-α ANTIBODIES
11/06/2003WO2002062945A3 Compositions and methods relating to lung specific genes and proteins
11/06/2003WO2002059312A3 Cell adhesion proteins
11/06/2003WO2002053742A3 Proteins and nucleic acids encoding same
11/06/2003WO2002050260A3 Process for the production and purification of secreted proteins ans the production of arrays of proteins
11/06/2003WO2002046437A3 Methods and compositions for highly efficient production of heterologous proteins in yeast
11/06/2003WO2002044210A3 Novel human nucleic acid molecules and polypeptides encoding a novel human ion channel expressed in spinal cord and brain
11/06/2003WO2002044199A3 Neurotoxins with enhanced target specificity
11/06/2003WO2002024891A9 B7-like molecules and uses thereof
11/06/2003WO2001080633A8 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema
11/06/2003WO2001078503A3 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
11/06/2003US20030208783 Transcriptional activator fusion proteins which comprises both tetracycline controlled transactivator proteins and reverse tetracycline transactivator proteins
11/06/2003US20030208782 Isolation and characterization of the Monogenic Audiogenic Seizure- susceptible (MASS1) gene; the gene is related to epilepsy
11/06/2003US20030208781 By immunization with any desired antigen
11/06/2003US20030208780 Useful in preparing recombinant cells for diagnosis and therapy of human tumors
11/06/2003US20030208058 B7-like polypeptides and polynucleotides
11/06/2003US20030208055 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030208054 Fc Receptors and polypeptides
11/06/2003US20030208048 Anti-alphavbeta3 recombinant human antibodies, nucleic acids encoding same and methods of use
11/06/2003US20030208045 Binds to Osteoclastogenesis Inhibitory Factor (OCIF) binding molecule (OBM)
1 ... 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 ... 1125